Biomx Ltd (PHGE) Stock Price, Quote & News

Company Profile

BiomX Inc., a clinical-stage biopharmaceutical company, develops phage-based therapies using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company's phage-based therapies include fixed cocktail therapy, which involves developing a single product containing a fixed number of selected phages to cover a range of bacterial strains; and personalized therapy, which involves developing a large library of phages from...

Industry: Biotechnology

Sector: Healthcare

Website: www.biomx.com

Address:

850 New Burton Road, Suite 201, Dover, United States

toffernelson May. 11 at 4:51 PM

$PHGE 👀

0 · Reply

forsiz1 May. 11 at 4:12 PM

$PHGE Earnings within a few weeks 🚀 Ready to 💣 💣 💣

0 · Reply

toffernelson May. 7 at 1:08 PM

$PHGE "At Zorronet, we listen to the needs of the people in the field, specifically the people on the ground and security experts,” said Idan Wasserman, CEO of Zorronet. “We are proud to have successfully designed and developed an application that combines the newest worlds of security, command-and-control, AI, and operational communication with what operators on the ground are looking for. We tested the application alongside leading security professionals in real operational scenarios, and built a system that not only delivers information, but helps users understand what is happening and what to do next in real time.” https://ca.finance.yahoo.com/news/biomx-zorronet-puts-full-ai-201500767.html?guccounter=1

0 · Reply

forsiz1 May. 7 at 12:54 AM

$PHGE 3 tomorrow then 5 by friday 🚀

0 · Reply

TheMACDaddy May. 6 at 9:07 PM

$PHGE More AH volume than day trading, we need this to continue tomorrow for some real gains 💪🏻

0 · Reply

zx_l May. 6 at 8:37 PM

$PHGE https://ca.finance.yahoo.com/news/biomx-zorronet-puts-full-ai-201500767.html

0 · Reply

najch May. 6 at 8:17 PM

$PHGE reading their latest 8-K is like a parade... almost every risk there could possibly exist & it's like 13 people in the entire company left

1 · Reply

najch May. 6 at 8:07 PM

$PHGE is that sidewalk dirt - only for poor people (used to be long back in the bio days)

0 · Reply

toffernelson May. 5 at 4:05 PM

$PHGE And what does this make you? Neil said the same. And yet he’s the scam and you’re… ?

2 · Reply

cupcakes4jesus May. 5 at 1:53 PM

$PHGE Neil Bhatia is the biggest fraud scam on X

0 · Reply

BiomX's Zorronet Puts Full AI Command-and-Control in the Palm of Your Hand

Apr 16, 2026, 4:30 PM EDT - 26 days ago

Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems

2026-04-13T13:24:40.000Z - 4 weeks ago

BiomX accelerates exercise of exclusive option to acquire DFSL option

Apr 13, 2026, 9:20 AM EDT - 4 weeks ago

BiomX Accelerates Defense Technology Buildout with DFSL Acquisition

Apr 10, 2026, 8:30 AM EDT - 4 weeks ago

BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications

2026-04-09T18:36:16.000Z - 4 weeks ago

Biomx Inc trading halted, news pending

2026-04-01T14:10:15.000Z - 5 weeks ago

Biomx Inc trading resumes

2026-04-01T13:38:15.000Z - 5 weeks ago

Biomx Inc trading halted, news pending

Mar 31, 2026, 10:48 AM EDT - 6 weeks ago

BiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone System

Mar 30, 2026, 9:28 AM EDT - 6 weeks ago

BiomX Adds Former Mossad Deputy to Advisory Board

2026-03-27T20:40:15.000Z - 6 weeks ago

BiomX receives noncompliance notification from Nasdaq

Mar 27, 2026, 4:30 PM EDT - 6 weeks ago

BiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency

2026-03-26T13:08:14.000Z - 6 weeks ago

BiomX launches X Security & Defense subsidiary in Israel

Mar 26, 2026, 8:48 AM EDT - 6 weeks ago

BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its Operations

2026-03-19T13:20:44.000Z - 7 weeks ago

BiomX issues letter to shareholders

Mar 19, 2026, 9:15 AM EDT - 7 weeks ago

BiomX CEO Issues Letter to Stockholders

Mar 11, 2026, 8:00 AM EDT - 2 months ago

BiomX Transcript: EGM 2026

2026-03-09T14:55:29.000Z - 2 months ago

BiomX downgraded to Neutral from Buy at H.C. Wainwright

2026-03-09T13:07:20.000Z - 2 months ago

BiomX names Michael Oster as CEO, David Rokach as CFO

Mar 9, 2026, 9:00 AM EDT - 2 months ago

BiomX Names Michael Oster as Chief Executive Officer, David Rokach Chief Financial Officer to Support Next Phase of Growth

2026-03-05T16:00:36.000Z - 2 months ago

Biomx Inc trading resumes

2026-03-05T15:55:32.000Z - 2 months ago

Biomx Inc trading halted, volatility trading pause

Feb 25, 2026, 8:00 AM EST - 2 months ago

BiomX Transcript: EGM 2026

2026-02-09T21:40:33.000Z - 3 months ago

BiomX files to sell 5.31M shares of common stock for holders

2026-01-29T14:50:55.000Z - 3 months ago

Biomx Inc trading resumes

2026-01-29T14:46:29.000Z - 3 months ago

Biomx Inc trading halted, volatility trading pause

Jan 27, 2026, 1:41 PM EST - 3 months ago

BiomX Issues Statement Regarding Recent Common Stock Trading Activity

2025-12-29T13:15:13.000Z - 4 months ago

BiomX announces $3M private placement

Dec 29, 2025, 8:00 AM EST - 4 months ago

BiomX Announces $3.0 Million Private Placement

2025-12-08T12:36:04.000Z - 5 months ago

BiomX discontinues Phase 2b BX004 trial, plans cost-cutting measures

2025-11-25T21:45:24.000Z - 6 months ago

BiomX provides update on BX004 Phase 2b trial in Cystic Fibrosis

Nov 25, 2025, 4:40 PM EST - 6 months ago

BiomX Provides Update on BX004 Phase 2b Trial in Cystic Fibrosis

2025-11-25T11:10:33.000Z - 6 months ago

BiomX price target adjusted to $26 from $15 at H.C. Wainwright

2025-11-14T21:40:22.000Z - 6 months ago

BiomX announces 1-for-19 reverse stock split

Nov 12, 2025, 8:30 AM EST - 6 months ago

BiomX Earnings Call Transcript: Q3 2025

Nov 12, 2025, 7:30 AM EST - 6 months ago

BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates

Oct 17, 2025, 8:30 AM EDT - 7 months ago

BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways

Aug 19, 2025, 8:19 AM EDT - 9 months ago

BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis

Aug 13, 2025, 8:00 AM EDT - 9 months ago

BiomX Earnings Call Transcript: Q2 2025

Aug 13, 2025, 6:30 AM EDT - 9 months ago

BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates

Aug 6, 2025, 8:30 AM EDT - 10 months ago

BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025

Jul 14, 2025, 9:00 AM EDT - 10 months ago

BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis

Jul 8, 2025, 8:30 AM EDT - 11 months ago

BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis

May 19, 2025, 10:02 AM EDT - 1 year ago

BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference

May 15, 2025, 2:00 PM EDT - 1 year ago

BiomX Earnings Call Transcript: Q1 2025

May 15, 2025, 6:30 AM EDT - 1 year ago

BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates

May 8, 2025, 7:00 AM EDT - 1 year ago

BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025

Apr 3, 2025, 11:00 AM EDT - 1 year ago

BiomX Transcript: KOL Event

Apr 1, 2025, 6:30 AM EDT - 1 year ago

BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure

Mar 31, 2025, 9:00 AM EDT - 1 year ago

BiomX Earnings Call Transcript: Q4 2024

Mar 31, 2025, 6:30 AM EDT - 1 year ago

BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)

Mar 25, 2025, 6:30 AM EDT - 1 year ago

BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates

Mar 19, 2025, 12:35 PM EDT - 1 year ago

BiomX to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

Nov 14, 2024, 8:00 AM EST - 1 year ago

BiomX Earnings Call Transcript: Q3 2024

Nov 14, 2024, 6:30 AM EST - 1 year ago

BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates

Nov 12, 2024, 12:20 PM EST - 1 year ago

BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024

Oct 15, 2024, 7:00 AM EDT - 1 year ago

BiomX Announces a Mandatory Unit Separation

Sep 18, 2024, 8:00 AM EDT - 1 year ago

BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference

Sep 9, 2024, 7:00 AM EDT - 1 year ago

BiomX Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 4, 2024, 8:00 AM EDT - 1 year ago

BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 16, 2024, 10:55 AM EDT - 1 year ago

UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock Split

Aug 15, 2024, 8:00 AM EDT - 1 year ago

BiomX Earnings Call Transcript: Q2 2024

Aug 15, 2024, 6:30 AM EDT - 1 year ago

BiomX Inc. Announces 1-for-10 Reverse Stock Split

Aug 15, 2024, 6:30 AM EDT - 1 year ago

BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates

Aug 8, 2024, 7:00 AM EDT - 1 year ago

BiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024

Jul 29, 2024, 7:00 AM EDT - 1 year ago

BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing Compliance

Jul 10, 2024, 6:30 AM EDT - 2 years ago

BiomX Inc. Announces Stockholder Approval for Conversion of Outstanding Series X Convertible Preferred Stock to Common Stock

May 30, 2024, 4:50 PM EDT - 2 years ago

BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

May 30, 2024, 7:00 AM EDT - 2 years ago

BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024

May 21, 2024, 8:00 AM EDT - 2 years ago

BiomX Earnings Call Transcript: Q1 2024

May 21, 2024, 6:30 AM EDT - 2 years ago

BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates

May 15, 2024, 7:00 AM EDT - 2 years ago

BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024

Apr 23, 2024, 8:00 AM EDT - 2 years ago

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

Apr 18, 2024, 8:00 AM EDT - 2 years ago

BiomX Announces the Appointment of Susan Blum to its Board of Directors

Apr 3, 2024, 8:00 AM EDT - 2 years ago

BiomX Earnings Call Transcript: Q4 2023

Apr 3, 2024, 6:30 AM EDT - 2 years ago

BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 27, 2024, 6:30 AM EDT - 2 years ago

BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024

Mar 18, 2024, 6:30 AM EDT - 2 years ago

BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing

Mar 6, 2024, 7:30 AM EST - 2 years ago

BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing

Jan 4, 2024, 8:00 AM EST - 2 years ago

BiomX Receives Orphan Drug Designation from the U.S. Food and Drug Administration for BX004 for the Treatment of Chronic Pulmonary Infection Caused by Pseudomonas aeruginosa in Patients with Cystic Fibrosis

toffernelson May. 11 at 4:51 PM

$PHGE 👀

0 · Reply

forsiz1 May. 11 at 4:12 PM

$PHGE Earnings within a few weeks 🚀 Ready to 💣 💣 💣

0 · Reply

toffernelson May. 7 at 1:08 PM

0 · Reply

forsiz1 May. 7 at 12:54 AM

$PHGE 3 tomorrow then 5 by friday 🚀

0 · Reply

TheMACDaddy May. 6 at 9:07 PM

$PHGE More AH volume than day trading, we need this to continue tomorrow for some real gains 💪🏻

0 · Reply

zx_l May. 6 at 8:37 PM

$PHGE https://ca.finance.yahoo.com/news/biomx-zorronet-puts-full-ai-201500767.html

0 · Reply

najch May. 6 at 8:17 PM

$PHGE reading their latest 8-K is like a parade... almost every risk there could possibly exist & it's like 13 people in the entire company left

1 · Reply

najch May. 6 at 8:07 PM

$PHGE is that sidewalk dirt - only for poor people (used to be long back in the bio days)

0 · Reply

toffernelson May. 5 at 4:05 PM

$PHGE And what does this make you? Neil said the same. And yet he’s the scam and you’re… ?

2 · Reply

cupcakes4jesus May. 5 at 1:53 PM

$PHGE Neil Bhatia is the biggest fraud scam on X

0 · Reply

kamenrider888 May. 4 at 11:36 PM

$PHGE

0 · Reply

kamenrider888 May. 4 at 11:34 PM

$PHGE LMAO as I predicted many months ago,,reverse stock split into infinity scam stock from $14 to 70CENTS LMAO. Just look at the all time chart..i has flatlined already.. scammy management. Boler room bots just pumping this to naiive investors lol

1 · Reply

Moon1987 May. 4 at 11:26 PM

$DFNS $ABVE $PHGE $AMZE im a loud voice and openly criticised yours and Bhatias bulls”””t stocks that you try and fool retail with. PHGE at 5$ its going up.. in 4 weeks its now 0.75c. DFNS 7$ its going to 25$ (Neil Bhatias spouting daily price predicition) its now at 0.42c. Amze at 0.14c from 0.70c when you guys were shouting 2$ Oh btw i am a MAN unlike you, i also hold a considerable net worth my little dorky friend and own my own company, fully retired by age of 30, and finally, you say holds zero weight? You went crying to Stockwits CEO and tagged him to stop me from ousting you .. i call that considerable weight if i got to you that much. Now keep poking the bear and you shall reap continuous daily prods 🤪❤️

5 · Reply

exp8triot May. 4 at 11:21 PM

$DFNS @toffernelson you hooked me up heavily with $GILT and that paid off last year. I just loaded the boat with $DFNS I trust your instincts. I am waitin on the sidelines for $AMZE and $PHGE

1 · Reply

forsiz1 May. 4 at 6:36 PM

$PHGE Q1 earnings in a few weeks 👍 😎 Waiting to get updates from the new mgt team 😀 🚀

0 · Reply

forsiz1 May. 1 at 4:32 PM

$PHGE BIG NEWS COMING .... I CAN FEEL IT 👍

1 · Reply